Compare MBOT & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBOT | NXPL |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.9M | 24.3M |
| IPO Year | 2000 | 2011 |
| Metric | MBOT | NXPL |
|---|---|---|
| Price | $1.46 | $8.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 660.4K | 42.6K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.27 | 35.29 |
| EPS | ★ N/A | N/A |
| Revenue | $116,887.00 | ★ $5,869,558.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $119.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.50 |
| 52 Week Low | $1.44 | $0.34 |
| 52 Week High | $3.74 | $9.94 |
| Indicator | MBOT | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 39.24 | 60.08 |
| Support Level | $1.44 | $5.54 |
| Resistance Level | $2.20 | $9.94 |
| Average True Range (ATR) | 0.05 | 0.60 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 11.54 | 24.92 |
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.